18 0 2 0 2 B-language_fluency
years 3 8 3 8 I-language_fluency
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

Absolute 0 8 25 33 B-clinical_variable
Neutrophil 9 19 34 44 I-clinical_variable
Count 20 25 45 50 I-clinical_variable
( 26 27 51 52 I-clinical_variable
ANC 27 30 52 55 I-clinical_variable
) 30 31 55 56 I-clinical_variable
≥ 32 33 57 58 O
1000 34 38 59 63 B-lower_bound
/ 38 39 63 64 I-lower_bound
mm3 39 42 64 67 I-lower_bound

Active 0 6 68 74 B-chronic_disease
uncontrolled 7 19 75 87 I-chronic_disease
infection 20 29 88 97 I-chronic_disease

Anti 0 4 98 102 B-treatment
- 4 5 102 103 I-treatment
cancer 5 11 103 109 I-treatment
Agents 12 18 110 116 I-treatment
: 18 19 116 117 O
Anti 20 24 118 122 B-treatment
- 24 25 122 123 I-treatment
cancer 25 31 123 129 I-treatment
agents 32 38 130 136 I-treatment
are 39 42 137 140 O
not 43 46 141 144 O
permitted 47 56 145 154 O
within 57 63 155 161 O
21 64 66 162 164 B-upper_bound
days 67 71 165 169 I-upper_bound
prior 72 77 170 175 I-upper_bound
to 78 80 176 178 O
start 81 86 179 184 O
of 87 89 185 187 O
POPI 90 94 188 192 B-treatment

Any 0 3 193 196 O
other 4 9 197 202 O
illness 10 17 203 210 O
condition(s 18 29 211 222 O
) 29 30 222 223 O
that 31 35 224 228 O
could 36 41 229 234 O
exacerbate 42 52 235 245 O
potential 53 62 246 255 O
toxicities 63 73 256 266 O
, 73 74 266 267 O
confound 75 83 268 276 O
safety 84 90 277 283 O
assessments 91 102 284 295 O
, 102 103 295 296 O
require 104 111 297 304 O
excluded 112 120 305 313 O
therapy 121 128 314 321 B-treatment
for 129 132 322 325 O
management 133 143 326 336 O
, 143 144 336 337 O
or 145 147 338 340 O
limit 148 153 341 346 O
compliance 154 164 347 357 O
with 165 169 358 362 O
study 170 175 363 368 O
requirements 176 188 369 381 O

Bilirubin 0 9 382 391 B-clinical_variable
≤ 10 11 392 393 O
1.5 12 15 394 397 B-upper_bound
mg 16 18 398 400 I-upper_bound
/ 18 19 400 401 I-upper_bound
dL 19 21 401 403 I-upper_bound
( 22 23 404 405 O
≤ 23 24 405 406 O
3.0 25 28 407 410 B-upper_bound
mg 29 31 411 413 I-upper_bound
/ 31 32 413 414 I-upper_bound
dL 32 34 414 416 I-upper_bound
with 35 39 417 421 O
liver 40 45 422 427 B-cancer
metastasis 46 56 428 438 I-cancer
) 56 57 438 439 O

Bisphosphonates 0 15 440 455 B-treatment
, 15 16 455 456 O
hormone 17 24 457 464 B-treatment
modification 25 37 465 477 I-treatment
therapy 38 45 478 485 I-treatment
, 45 46 485 486 O
and 47 50 487 490 O
trastuzumab 51 62 491 502 B-treatment
are 63 66 503 506 O
permitted 67 76 507 516 O
without 77 84 517 524 O
restriction 85 96 525 536 O

Clinically 0 10 537 547 O
significant 11 22 548 559 O
and 23 26 560 563 O
uncontrolled 27 39 564 576 O
major 40 45 577 582 O
cardiac 46 53 583 590 B-chronic_disease
, 53 54 590 591 O
respiratory 55 66 592 603 B-chronic_disease
, 66 67 603 604 O
renal 68 73 605 610 B-chronic_disease
, 73 74 610 611 O
hepatic 75 82 612 619 B-chronic_disease
, 82 83 619 620 O
gastrointestinal 84 100 621 637 B-chronic_disease
, 100 101 637 638 O
hematologic 102 113 639 650 B-chronic_disease
or 114 116 651 653 O
neurological 117 129 654 666 B-chronic_disease
/ 129 130 666 667 I-chronic_disease
psychiatric 130 141 667 678 I-chronic_disease
disease 142 149 679 686 I-chronic_disease
or 150 152 687 689 O
disorder 153 161 690 698 B-chronic_disease

Consideration 0 13 699 712 O
by 14 16 713 715 O
the 17 20 716 719 O
Investigator 21 33 720 732 O
, 33 34 732 733 O
for 35 38 734 737 O
any 39 42 738 741 O
reason 43 49 742 748 O
, 49 50 748 749 O
that 51 55 750 754 O
the 56 59 755 758 O
subject 60 67 759 766 O
is 68 70 767 769 O
an 71 73 770 772 O
unsuitable 74 84 773 783 O
candidate 85 94 784 793 O
to 95 97 794 796 O
receive 98 105 797 804 O
veliparib 106 115 805 814 B-treatment
( 116 117 815 816 I-treatment
ABT-888 117 124 816 823 I-treatment
) 124 125 823 824 I-treatment
and/or 126 132 825 831 O
breast 133 139 832 838 B-treatment
irradiation 140 151 839 850 I-treatment

Creatinine 0 10 851 861 B-clinical_variable
Serum 11 16 862 867 I-clinical_variable
≤ 17 18 868 869 O
2.0 19 22 870 873 B-upper_bound
mg 23 25 874 876 I-upper_bound
/ 25 26 876 877 I-upper_bound
dl 26 28 877 879 I-upper_bound
or 29 31 880 882 O
Creatinine 32 42 883 893 B-clinical_variable
Clearance 43 52 894 903 I-clinical_variable
≥45mL 53 58 904 909 O
/ 58 59 909 910 I-lower_bound
min 59 62 910 913 I-lower_bound

Double 0 6 914 920 B-contraception_consent
- 6 7 920 921 I-contraception_consent
barrier 7 14 921 928 I-contraception_consent
method 15 21 929 935 I-contraception_consent
( 22 23 936 937 O
condoms 23 30 937 944 B-contraception_consent
, 30 31 944 945 O
contraceptive 32 45 946 959 B-contraception_consent
sponge 46 52 960 966 I-contraception_consent
, 52 53 966 967 O
diaphragm 54 63 968 977 B-contraception_consent
or 64 66 978 980 I-contraception_consent
vaginal 67 74 981 988 I-contraception_consent
ring 75 79 989 993 I-contraception_consent
with 80 84 994 998 I-contraception_consent
spermicidal 85 96 999 1010 I-contraception_consent
jellies 97 104 1011 1018 I-contraception_consent
or 105 107 1019 1021 I-contraception_consent
cream 108 113 1022 1027 I-contraception_consent
) 113 114 1027 1028 O

For 0 3 1029 1032 O
purposes 4 12 1033 1041 O
of 13 15 1042 1044 O
this 16 20 1045 1049 O
protocol 21 29 1050 1058 O
, 29 30 1058 1059 O
anti 31 35 1060 1064 B-treatment
- 35 36 1064 1065 I-treatment
tumor 36 41 1065 1070 I-treatment
treatment 42 51 1071 1080 I-treatment
may 52 55 1081 1084 O
be 56 58 1085 1087 O
defined 59 66 1088 1095 O
as 67 69 1096 1098 O
, 69 70 1098 1099 O
but 71 74 1100 1103 O
is 75 77 1104 1106 O
not 78 81 1107 1110 O
limited 82 89 1111 1118 O
to 90 92 1119 1121 O
, 92 93 1121 1122 O
anti 94 98 1123 1127 B-treatment
- 98 99 1127 1128 I-treatment
cancer 99 105 1128 1134 I-treatment
agents 106 112 1135 1141 I-treatment
( 113 114 1142 1143 O
cytotoxic 114 123 1143 1152 B-treatment
chemotherapy 124 136 1153 1165 B-treatment
, 136 137 1165 1166 O
immunotherapy 138 151 1167 1180 B-treatment
, 151 152 1180 1181 O
biologic 153 161 1182 1190 B-treatment
therapy 162 169 1191 1198 I-treatment
) 169 170 1198 1199 O
, 170 171 1199 1200 O
radiotherapy 172 184 1201 1213 B-treatment
, 184 185 1213 1214 O
and 186 189 1215 1218 O
investigational 190 205 1219 1234 B-treatment
agents 206 212 1235 1241 I-treatment

Hemoglobin 0 10 1242 1252 B-clinical_variable
≥ 11 12 1253 1254 O
9.0 13 16 1255 1258 B-lower_bound
g 17 18 1259 1260 I-lower_bound
/ 18 19 1260 1261 I-lower_bound
dL 19 21 1261 1263 I-lower_bound

Hepatic 0 7 1264 1271 B-treatment
Function 8 16 1272 1280 I-treatment

History 0 7 1281 1288 O
of 8 10 1289 1291 O
immediate 11 20 1292 1301 O
or 21 23 1302 1304 O
delayed 24 31 1305 1312 O
hypersensitivity 32 48 1313 1329 O
reaction 49 57 1330 1338 O
or 58 60 1339 1341 O
other 61 66 1342 1347 O
contraindication 67 83 1348 1364 O
to 84 86 1365 1367 O
contrast 87 95 1368 1376 O
agents 96 102 1377 1383 O
including 103 112 1384 1393 O
but 113 116 1394 1397 O
not 117 120 1398 1401 O
limited 121 128 1402 1409 O
to 129 131 1410 1412 O
gadolinium 132 142 1413 1423 B-allergy_name
and 143 146 1424 1427 O
iodine 147 153 1428 1434 B-allergy_name

History 0 7 1435 1442 O
of 8 10 1443 1445 O
seizure 11 18 1446 1453 B-chronic_disease
disorder 19 27 1454 1462 I-chronic_disease

Hormonal 0 8 1463 1471 B-contraception_consent
contraceptives 9 23 1472 1486 I-contraception_consent
( 24 25 1487 1488 O
oral 25 29 1488 1492 O
, 29 30 1492 1493 O
parenteral 31 41 1494 1504 O
or 42 44 1505 1507 O
transdermal 45 56 1508 1519 O
) 56 57 1519 1520 O
for 58 61 1521 1524 O
at 62 64 1525 1527 O
least 65 70 1528 1533 O
3 71 72 1534 1535 B-lower_bound
months 73 79 1536 1542 I-lower_bound
prior 80 85 1543 1548 I-lower_bound
to 86 88 1549 1551 O
study 89 94 1552 1557 O
drug 95 99 1558 1562 O
administration 100 114 1563 1577 O

Hormonal 0 8 1578 1586 B-treatment
therapy 9 16 1587 1594 I-treatment
and 17 20 1595 1598 O
Traztusumab 21 32 1599 1610 B-treatment

If 0 2 1611 1613 O
calculated 3 13 1614 1624 O
creatinine 14 24 1625 1635 B-clinical_variable
clearance 25 34 1636 1645 I-clinical_variable
is 35 37 1646 1648 O
< 38 39 1649 1650 O
45 40 42 1651 1653 B-upper_bound
mL 43 45 1654 1656 I-upper_bound
/ 45 46 1656 1657 I-upper_bound
min 46 49 1657 1660 I-upper_bound
, 49 50 1660 1661 O
a 51 52 1662 1663 O
24 53 55 1664 1666 O
- 55 56 1666 1667 O
hour 56 60 1667 1671 O
urine 61 66 1672 1677 O
collection 67 77 1678 1688 O
for 78 81 1689 1692 O
creatinine 82 92 1693 1703 O
clearance 93 102 1704 1713 O
may 103 106 1714 1717 O
be 107 109 1718 1720 O
performed 110 119 1721 1730 O

If 0 2 1731 1733 O
female 3 9 1734 1740 B-gender
, 9 10 1740 1741 O
subject 11 18 1742 1749 O
is 19 21 1750 1752 O
pregnant 22 30 1753 1761 B-pregnancy
or 31 33 1762 1764 O
breast 34 40 1765 1771 O
- 40 41 1771 1772 O
feeding 41 48 1772 1779 O

Known 0 5 1780 1785 O
contraindication 6 22 1786 1802 O
to 23 25 1803 1805 O
enhanced 26 34 1806 1814 O
MRI 35 38 1815 1818 B-treatment
and 39 42 1819 1822 O
CT 43 45 1823 1825 B-treatment

Last 0 4 1826 1830 O
dose 5 9 1831 1835 O
of 10 12 1836 1838 O
chemotherapy 13 25 1839 1851 B-treatment
, 25 26 1851 1852 O
immunotherapy 27 40 1853 1866 B-treatment
, 40 41 1866 1867 O
biologic 42 50 1868 1876 B-treatment
therapy 51 58 1877 1884 I-treatment
, 58 59 1884 1885 O
or 60 62 1886 1888 O
investigational 63 78 1889 1904 B-treatment
therapy 79 86 1905 1912 I-treatment
, 86 87 1912 1913 O
was 88 91 1914 1917 O
less 92 96 1918 1922 O
than 97 101 1923 1927 O
14 102 104 1928 1930 B-upper_bound
days 105 109 1931 1935 I-upper_bound
prior 110 115 1936 1941 I-upper_bound
to 116 118 1942 1944 O
protocol 119 127 1945 1953 O
therapy 128 135 1954 1961 O
( 136 137 1962 1963 O
radiation 137 146 1963 1972 B-treatment
and 147 150 1973 1976 O
veliparib 151 160 1977 1986 B-treatment
) 160 161 1986 1987 O

No 0 2 1988 1990 O
other 3 8 1991 1996 O
prior 9 14 1997 2002 O
malignancy 15 25 2003 2013 B-cancer
is 26 28 2014 2016 O
allowed 29 36 2017 2024 O
except 37 43 2025 2031 O
for 44 47 2032 2035 O
adequately 48 58 2036 2046 O
treated 59 66 2047 2054 O
basal 67 72 2055 2060 B-chronic_disease
cell 73 77 2061 2065 I-chronic_disease
or 78 80 2066 2068 O
squamous 81 89 2069 2077 B-cancer
cell 90 94 2078 2082 I-cancer
skin 95 99 2083 2087 I-cancer
cancer 100 106 2088 2094 I-cancer
, 106 107 2094 2095 O
in 108 110 2096 2098 B-cancer
situ 111 115 2099 2103 I-cancer
cervical 116 124 2104 2112 I-cancer
cancer 125 131 2113 2119 I-cancer
, 131 132 2119 2120 O
or 133 135 2121 2123 O
any 136 139 2124 2127 O
other 140 145 2128 2133 O
cancer 146 152 2134 2140 O
from 153 157 2141 2145 O
which 158 163 2146 2151 O
the 164 167 2152 2155 O
patient 168 175 2156 2163 O
has 176 179 2164 2167 O
been 180 184 2168 2172 O
disease 185 192 2173 2180 O
- 192 193 2180 2181 O
free 193 197 2181 2185 O
for 198 201 2186 2189 O
5 202 203 2190 2191 B-upper_bound
years 204 209 2192 2197 I-upper_bound

Patient 0 7 2198 2205 O
must 8 12 2206 2210 O
have 13 17 2211 2215 O
> 18 19 2216 2217 O
1.0 20 23 2218 2221 B-lower_bound
cm 24 26 2222 2224 I-lower_bound
residual 27 35 2225 2233 O
in 36 38 2234 2236 O
- 38 39 2236 2237 O
breast 39 45 2237 2243 B-cancer
cancer 46 52 2244 2250 I-cancer
and/or 53 59 2251 2257 O
clinically 60 70 2258 2268 O
positive 71 79 2269 2277 B-cancer
residual 80 88 2278 2286 I-cancer
nodal 89 94 2287 2292 I-cancer
disease 95 102 2293 2300 I-cancer

Patient 0 7 2301 2308 O
must 8 12 2309 2313 O
have 13 17 2314 2318 O
a 18 19 2319 2320 O
history 20 27 2321 2328 O
and 28 31 2329 2332 O
physical 32 40 2333 2341 O
within 41 47 2342 2348 O
2 48 49 2349 2350 B-upper_bound
weeks 50 55 2351 2356 I-upper_bound
prior 56 61 2357 2362 I-upper_bound
to 62 64 2363 2365 O
the 65 68 2366 2369 O
start 69 74 2370 2375 O
of 75 77 2376 2378 O
any 78 81 2379 2382 O
protocol 82 90 2383 2391 B-treatment
therapy 91 98 2392 2399 I-treatment

Patients 0 8 2400 2408 O
must 9 13 2409 2413 O
have 14 18 2414 2418 O
a 19 20 2419 2420 O
performance 21 32 2421 2432 B-clinical_variable
status 33 39 2433 2439 I-clinical_variable
0 40 41 2440 2441 B-lower_bound
or 42 44 2442 2444 O
1 45 46 2445 2446 B-upper_bound
by 47 49 2447 2449 O
ECOG 50 54 2450 2454 B-clinical_variable
criteria 55 63 2455 2463 O

Patients 0 8 2464 2472 O
must 9 13 2473 2477 B-pregnancy
not 14 17 2478 2481 I-pregnancy
be 18 20 2482 2484 I-pregnancy
pregnant 21 29 2485 2493 I-pregnancy
due 30 33 2494 2497 O
to 34 36 2498 2500 O
the 37 40 2501 2504 O
potential 41 50 2505 2514 O
for 51 54 2515 2518 O
fetal 55 60 2519 2524 O
harm 61 65 2525 2529 O
as 66 68 2530 2532 O
a 69 70 2533 2534 O
result 71 77 2535 2541 O
of 78 80 2542 2544 O
this 81 85 2545 2549 O
treatment 86 95 2550 2559 B-treatment
regimen 96 103 2560 2567 I-treatment

Patients 0 8 2568 2576 O
must 9 13 2577 2581 O
not 14 17 2582 2585 O
have 18 22 2586 2590 O
a 23 24 2591 2592 O
serious 25 32 2593 2600 O
medical 33 40 2601 2608 B-chronic_disease
or 41 43 2609 2611 O
psychiatric 44 55 2612 2623 B-chronic_disease
illness 56 63 2624 2631 I-chronic_disease
which 64 69 2632 2637 O
prevents 70 78 2638 2646 O
informed 79 87 2647 2655 O
consent 88 95 2656 2663 O
or 96 98 2664 2666 O
compliance 99 109 2667 2677 O
with 110 114 2678 2682 O
treatment 115 124 2683 2692 B-treatment

Patients 0 8 2693 2701 O
with 9 13 2702 2706 O
squamous 14 22 2707 2715 B-cancer
, 22 23 2715 2716 O
or 24 26 2717 2719 O
metaplastic 27 38 2720 2731 B-cancer
carcinomas 39 49 2732 2742 I-cancer
or 50 52 2743 2745 O
sarcomas 53 61 2746 2754 B-cancer
of 62 64 2755 2757 I-cancer
the 65 68 2758 2761 I-cancer
breast 69 75 2762 2768 I-cancer

Platelet 0 8 2769 2777 B-clinical_variable
Count 9 14 2778 2783 I-clinical_variable
≥ 15 16 2784 2785 O
100,000 17 24 2786 2793 B-lower_bound
/ 24 25 2793 2794 I-lower_bound
mm3 25 28 2794 2797 I-lower_bound

Presence 0 8 2798 2806 O
of 9 11 2807 2809 O
metal 12 17 2810 2815 O
objects 18 25 2816 2823 O
within 26 32 2824 2830 O
the 33 36 2831 2834 O
body 37 41 2835 2839 O
such 42 46 2840 2844 O
as 47 49 2845 2847 O
a 50 51 2848 2849 O
cardiac 52 59 2850 2857 O
pacemaker 60 69 2858 2867 B-treatment
, 69 70 2867 2868 O
implanted 71 80 2869 2878 B-treatment
cardiac 81 88 2879 2886 I-treatment
defibrillator 89 102 2887 2900 I-treatment
, 102 103 2900 2901 O
brain 104 109 2902 2907 B-treatment
aneurysm 110 118 2908 2916 I-treatment
clips 119 124 2917 2922 I-treatment
, 124 125 2922 2923 O
cochlear 126 134 2924 2932 B-treatment
implant 135 142 2933 2940 I-treatment
, 142 143 2940 2941 O
ocular 144 150 2942 2948 B-treatment
foreign 151 158 2949 2956 I-treatment
body 159 163 2957 2961 I-treatment
, 163 164 2961 2962 O
or 165 167 2963 2965 O
shrapnel 168 176 2966 2974 B-treatment

Previous 0 8 2975 2983 O
enrollment 9 19 2984 2994 O
on 20 22 2995 2997 O
another 23 30 2998 3005 O
study 31 36 3006 3011 O
involving 37 46 3012 3021 O
the 47 50 3022 3025 O
investigation 51 64 3026 3039 O
of 65 67 3040 3042 O
veliparib 68 77 3043 3052 B-treatment
( 78 79 3053 3054 I-treatment
ABT- 79 83 3054 3058 I-treatment
888 84 87 3059 3062 I-treatment
) 87 88 3062 3063 I-treatment
, 88 89 3063 3064 O
with 90 94 3065 3069 O
the 95 98 3070 3073 O
exception 99 108 3074 3083 O
of 109 111 3084 3086 O
receiving 112 121 3087 3096 O
a 122 123 3097 3098 O
single 124 130 3099 3105 O
dose 131 135 3106 3110 O
of 136 138 3111 3113 O
study 139 144 3114 3119 B-treatment
drug 145 149 3120 3124 I-treatment

Radiation 0 9 3125 3134 B-treatment
: 9 10 3134 3135 O
Prior 11 16 3136 3141 B-treatment
treatment 17 26 3142 3151 I-treatment
with 27 31 3152 3156 I-treatment
breast 32 38 3157 3163 I-treatment
irradiation 39 50 3164 3175 I-treatment
is 51 53 3176 3178 O
not 54 57 3179 3182 O
allowed 58 65 3183 3190 O
due 66 69 3191 3194 O
to 70 72 3195 3197 O
the 73 76 3198 3201 O
potential 77 86 3202 3211 O
for 87 90 3212 3215 O
cumulative 91 101 3216 3226 O
toxicities 102 112 3227 3237 O

Serum 0 5 3238 3243 B-clinical_variable
Glutamic 6 14 3244 3252 I-clinical_variable
- 14 15 3252 3253 I-clinical_variable
Oxaloacetic 15 26 3253 3264 I-clinical_variable
Transaminase 27 39 3265 3277 I-clinical_variable
( 40 41 3278 3279 I-clinical_variable
SGOT 41 45 3279 3283 I-clinical_variable
) 45 46 3283 3284 I-clinical_variable
≤ 47 48 3285 3286 O
2.5 49 52 3287 3290 B-upper_bound
× 53 54 3291 3292 I-upper_bound
ULN 55 58 3293 3296 B-clinical_variable
( 59 60 3297 3298 O
≤ 60 61 3298 3299 O
5.0 62 65 3300 3303 B-upper_bound
× 66 67 3304 3305 I-upper_bound
ULN 68 71 3306 3309 O
with 72 76 3310 3314 O
liver 77 82 3315 3320 B-cancer
metastasis 83 93 3321 3331 I-cancer
) 93 94 3331 3332 O

Serum 0 5 3333 3338 B-clinical_variable
Glutamic 6 14 3339 3347 I-clinical_variable
- 14 15 3347 3348 I-clinical_variable
Pyruvic 15 22 3348 3355 I-clinical_variable
Transaminase 23 35 3356 3368 I-clinical_variable
( 36 37 3369 3370 I-clinical_variable
SGPT 37 41 3370 3374 I-clinical_variable
) 41 42 3374 3375 I-clinical_variable
≤ 43 44 3376 3377 O
2.5 45 48 3378 3381 B-upper_bound
× 49 50 3382 3383 I-upper_bound
ULN 51 54 3384 3387 I-upper_bound
( 55 56 3388 3389 O
≤ 56 57 3389 3390 O
5.0 58 61 3391 3394 B-upper_bound
× 62 63 3395 3396 I-upper_bound
ULN 64 67 3397 3400 I-upper_bound
with 68 72 3401 3405 O
liver 73 78 3406 3411 B-cancer
metastasis 79 89 3412 3422 I-cancer
) 89 90 3422 3423 O
ULN 91 94 3424 3427 B-clinical_variable
= 95 96 3428 3429 I-clinical_variable
Upper 97 102 3430 3435 I-clinical_variable
normal 103 109 3436 3442 I-clinical_variable
limit 110 115 3443 3448 I-clinical_variable
of 116 118 3449 3451 I-clinical_variable
institution 119 130 3452 3463 I-clinical_variable
's 130 132 3463 3465 I-clinical_variable
normal 133 139 3466 3472 I-clinical_variable
range 140 145 3473 3478 I-clinical_variable

Subjects 0 8 3479 3487 O
with 9 13 3488 3492 O
Gilbert 14 21 3493 3500 B-treatment
's 21 23 3500 3502 I-treatment
disease 24 31 3503 3510 I-treatment
may 32 35 3511 3514 O
have 36 40 3515 3519 O
bilirubin 41 50 3520 3529 B-clinical_variable
up 51 53 3530 3532 O
to 54 56 3533 3535 O
2.5 57 60 3536 3539 B-lower_bound
mg 61 63 3540 3542 I-lower_bound
/ 63 64 3542 3543 I-lower_bound
dL 64 66 3543 3545 I-lower_bound
( 67 68 3546 3547 O
or 68 70 3547 3549 O
3.0 71 74 3550 3553 O
mg 75 77 3554 3556 O
/ 77 78 3556 3557 O
dL 78 80 3557 3559 O
with 81 85 3560 3564 O
liver 86 91 3565 3570 O
( 92 93 3571 3572 O
metastasis 93 103 3572 3582 B-cancer
) 103 104 3582 3583 O

Surgery 0 7 3584 3591 B-treatment
: 7 8 3591 3592 O
Incident 9 17 3593 3601 O
breast 18 24 3602 3608 B-treatment
biopsies 25 33 3609 3617 I-treatment
only 34 38 3618 3622 O
permitted 39 48 3623 3632 O
prior 49 54 3633 3638 O
to 55 57 3639 3641 O
POPI 58 62 3642 3646 B-treatment
to 63 65 3647 3649 O
confirm 66 73 3650 3657 O
residual 74 82 3658 3666 O
disease 83 90 3667 3674 O
after 91 96 3675 3680 O
NAC 97 100 3681 3684 B-treatment

Symptomatic 0 11 3685 3696 B-chronic_disease
congestive 12 22 3697 3707 I-chronic_disease
heart 23 28 3708 3713 I-chronic_disease
failure 29 36 3714 3721 I-chronic_disease
, 36 37 3721 3722 O
unstable 38 46 3723 3731 B-chronic_disease
angina 47 53 3732 3738 I-chronic_disease
pectoris 54 62 3739 3747 I-chronic_disease
, 62 63 3747 3748 O
or 64 66 3749 3751 O
cardiac 67 74 3752 3759 B-chronic_disease
arrhythmia 75 85 3760 3770 I-chronic_disease

Total 0 5 3771 3776 O
abstinence 6 16 3777 3787 O
from 17 21 3788 3792 O
sexual 22 28 3793 3799 O
intercourse 29 40 3800 3811 O
( 41 42 3812 3813 O
minimum 42 49 3813 3820 O
one 50 53 3821 3824 B-lower_bound
complete 54 62 3825 3833 O
menstrual 63 72 3834 3843 O
cycle 73 78 3844 3849 O
) 78 79 3849 3850 O

Unable 0 6 3851 3857 O
to 7 9 3858 3860 O
swallow 10 17 3861 3868 O
and 18 21 3869 3872 O
retain 22 28 3873 3879 O
oral 29 33 3880 3884 B-treatment
medications 34 45 3885 3896 I-treatment

Unresolved 0 10 3897 3907 O
or 11 13 3908 3910 O
unstable 14 22 3911 3919 O
, 22 23 3919 3920 O
serious 24 31 3921 3928 O
toxicity 32 40 3929 3937 O
from 41 45 3938 3942 O
prior 46 51 3943 3948 O
administration 52 66 3949 3963 O
of 67 69 3964 3966 O
another 70 77 3967 3974 O
investigational 78 93 3975 3990 B-treatment
drug 94 98 3991 3995 I-treatment
and/or 99 105 3996 4002 O
prior 106 111 4003 4008 B-treatment
anti 112 116 4009 4013 I-treatment
- 116 117 4013 4014 I-treatment
cancer 117 123 4014 4020 I-treatment
treatment 124 133 4021 4030 I-treatment

Women 0 5 4031 4036 B-gender
of 6 8 4037 4039 O
child 9 14 4040 4045 O
- 14 15 4045 4046 O
bearing 15 22 4046 4053 O
potential 23 32 4054 4063 O
must 33 37 4064 4068 O
also 38 42 4069 4073 O
have 43 47 4074 4078 O
a 48 49 4079 4080 O
negative 50 58 4081 4089 B-pregnancy
pregnancy 59 68 4090 4099 I-pregnancy
test 69 73 4100 4104 O
within 74 80 4105 4111 O
2 81 82 4112 4113 B-upper_bound
weeks 83 88 4114 4119 I-upper_bound
prior 89 94 4120 4125 I-upper_bound
to 95 97 4126 4128 O
start 98 103 4129 4134 O
of 104 106 4135 4137 O
protocol 107 115 4138 4146 O
therapy 116 123 4147 4154 B-treatment
( 124 125 4155 4156 O
radiation 125 134 4156 4165 B-treatment
and 135 138 4166 4169 O
veliparib 139 148 4170 4179 B-treatment
) 148 149 4179 4180 O

Women 0 5 4181 4186 B-gender
of 6 8 4187 4189 O
childbearing 9 21 4190 4202 O
potential 22 31 4203 4212 O
must 32 36 4213 4217 O
agree 37 42 4218 4223 B-contraception_consent
to 43 45 4224 4226 I-contraception_consent
use 46 49 4227 4230 I-contraception_consent
adequate 50 58 4231 4239 I-contraception_consent
contraception 59 72 4240 4253 I-contraception_consent

Women 0 5 4254 4259 B-gender
who 6 9 4260 4263 O
have 10 14 4264 4268 O
a 15 16 4269 4270 O
< 17 18 4271 4272 O
1.0 19 22 4273 4276 B-upper_bound
cm 23 25 4277 4279 I-upper_bound
and 26 29 4280 4283 O
are 30 33 4284 4287 O
cN0 34 37 4288 4291 O
after 38 43 4292 4297 O
NAC 44 47 4298 4301 B-treatment

female 0 6 4302 4308 B-gender

have 0 4 4309 4313 O
a 5 6 4314 4315 O
Medical 7 14 4316 4323 O
Oncology 15 23 4324 4332 O
consult 24 31 4333 4340 O
and 32 35 4341 4344 O
be 36 38 4345 4347 O
recommended 39 50 4348 4359 O
to 51 53 4360 4362 O
receive 54 61 4363 4370 O
neoadjuvant 62 73 4371 4382 B-treatment
chemotherapy 74 86 4383 4395 I-treatment
for 87 90 4396 4399 O
a 91 92 4400 4401 O
stage 93 98 4402 4407 B-cancer
IIB 99 102 4408 4411 I-cancer
through 103 110 4412 4419 I-cancer
IV 111 113 4420 4422 I-cancer
carcinoma 114 123 4423 4432 I-cancer

have 0 4 4433 4437 O
an 5 7 4438 4440 O
axillary 8 16 4441 4449 O
nodal 17 22 4450 4455 O
evaluation 23 33 4456 4466 O
by 34 36 4467 4469 O
fine 37 41 4470 4474 B-treatment
needle 42 48 4475 4481 I-treatment
aspiration 49 59 4482 4492 I-treatment
( 60 61 4493 4494 I-treatment
FNA 61 64 4494 4497 I-treatment
) 64 65 4497 4498 I-treatment
, 65 66 4498 4499 O
sentinel 67 75 4500 4508 B-treatment
node 76 80 4509 4513 I-treatment
biopsy 81 87 4514 4520 I-treatment
( 88 89 4521 4522 I-treatment
SNB 89 92 4522 4525 I-treatment
) 92 93 4525 4526 I-treatment
or 94 96 4527 4529 O
nodal 97 102 4530 4535 B-treatment
dissection 103 113 4536 4546 I-treatment

have 0 4 4547 4551 O
had 5 8 4552 4555 O
a 9 10 4556 4557 O
bilateral 11 20 4558 4567 B-treatment
mammogram 21 30 4568 4577 I-treatment
prior 31 36 4578 4583 O
to 37 39 4584 4586 O
NAC 40 43 4587 4590 B-treatment
unless 44 50 4591 4597 O
there 51 56 4598 4603 O
is 57 59 4604 4606 O
only 60 64 4607 4611 O
one 65 68 4612 4615 O
breast 69 75 4616 4622 O

have 0 4 4623 4627 O
histologically 5 19 4628 4642 O
confirmed 20 29 4643 4652 O
( 30 31 4653 4654 O
by 31 33 4654 4656 O
routine 34 41 4657 4664 O
H&E 42 45 4665 4668 O
staining 46 54 4669 4677 O
) 54 55 4677 4678 O
adenocarcinoma 56 70 4679 4693 B-cancer
of 71 73 4694 4696 O
the 74 77 4697 4700 O
breast 78 84 4701 4707 O
with 85 89 4708 4712 O
confirmed 90 99 4713 4722 O
nodal 100 105 4723 4728 B-cancer
metastasis 106 116 4729 4739 I-cancer

not 0 3 4740 4743 O
have 4 8 4744 4748 O
received 9 17 4749 4757 O
prior 18 23 4758 4763 B-treatment
radiation 24 33 4764 4773 I-treatment
therapy 34 41 4774 4781 I-treatment
to 42 44 4782 4784 O
the 45 48 4785 4788 O
involved 49 57 4789 4797 O
breast 58 64 4798 4804 O
at 65 67 4805 4807 O
any 68 71 4808 4811 O
time 72 76 4812 4816 O
for 77 80 4817 4820 O
any 81 84 4821 4824 O
reason 85 91 4825 4831 O

